首页> 外文期刊>The Journal of Urology >Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.
【24h】

Dihydroxyphenylglycol in pheochromocytoma: its diagnostic use for norepinephrine dominant tumor.

机译:嗜铬细胞瘤中的二羟基苯乙二醇:其用于去甲肾上腺素显性肿瘤的诊断用途。

获取原文
获取原文并翻译 | 示例
       

摘要

PURPOSE: To discern whether the 3,4-dihydroxyphenylglycol produced in adrenal medulla is associated with altered urinary excretion, we compared the tissue and urinary levels of this catecholamine metabolite, epinephrine and norepinephrine in 23 patients with pheochromocytoma and 26 subjects with renal cell carcinoma. MATERIALS AND METHODS: Tissue and urine concentrations of dihydroxyphenylglycol, epinephrine and norepinephrine were determined by catechol-O-methyl-transferase-based radioenzymatic method and high performance liquid chromatography with electrochemical detection. RESULTS: Contents of dihydroxyphenylglycol, epinephrine and norepinephrine in pheochromocytomas were higher than those in normal adrenal medullae. Removal of pheochromocytomas lowered urinary excretion of these catecholamines and dihydroxyphenylglycol. Norepinephrine content correlated closely with dihydroxyphenylglycol content in normal adrenal medullae and pheochromocytomas but not with epinephrine content in either tissue. Contents of norepinephrine and dihydroxyphenylglycol correlated significantly with urinary norepinephrine excretion and dihydroxyphenylglycol excretion in patients with pheochromocytoma but not in subjects with renal cell carcinoma. The norepinephrine-to-dihydroxyphenylglycol ratio in a 24-hour preoperative urine collection from patients with pheochromocytoma was higher than that from subjects with renal cell carcinoma, which was almost similar to that of epinephrine dominant pheochromocytomas. CONCLUSIONS: Our study suggests that dihydroxyphenylglycol in urine in subjects with renal cell carcinoma is predominantly of a neuronal origin and urinary dihydroxyphenylglycol in patients with pheochromocytoma is of tumor origin. A high level of norepinephrine-to-dihydroxyphenylglycol ratio in urine can be used to determine the diagnosis of the norepinephrine dominant type pheochromocytoma. Measurement of at least a few markers is preferable for precise biochemical diagnosis of pheochromocytoma.
机译:目的:为辨别肾上腺髓质中产生的3,4-二羟基苯乙二醇是否与尿排泄改变有关,我们比较了23名嗜铬细胞瘤患者和26名肾细胞癌患者中该儿茶酚胺代谢产物,肾上腺素和去甲肾上腺素的组织和尿水平。材料与方法:采用儿茶酚-O-甲基转移酶为基础的放射酶法和高效液相色谱-电化学检测法测定组织和尿液中二羟苯基乙二醇,肾上腺素和去甲肾上腺素的浓度。结果:嗜铬细胞瘤中二羟苯乙二醇,肾上腺素和去甲肾上腺素的含量高于正常肾上腺髓质。嗜铬细胞瘤的去除降低了这些儿茶酚胺和二羟基苯基二醇的尿排泄。去甲肾上腺素的含量与正常肾上腺髓质和嗜铬细胞瘤中的二羟苯基乙二醇含量密切相关,但与任一组织中的肾上腺素含量均不相关。在嗜铬细胞瘤患者中,去甲肾上腺素和二羟苯乙二醇的含量与尿中去甲肾上腺素的排泄和二羟苯乙二醇的排泄显着相关,而在肾细胞癌患者中则没有。嗜铬细胞瘤患者术前24小时尿液中去甲肾上腺素与二羟基苯乙二醇之比高于肾细胞癌患者,这几乎与肾上腺素占优势的嗜铬细胞瘤相似。结论:我们的研究表明,肾细胞癌患者尿液中的二羟基苯乙二醇主要来自神经元,而嗜铬细胞瘤患者的尿中二羟基苯乙二醇是肿瘤来源。尿液中去甲肾上腺素与二羟基苯乙二醇的比例高可用于确定去甲肾上腺素优势型嗜铬细胞瘤的诊断。为了精确地生化诊断嗜铬细胞瘤,优选至少测量几种标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号